IP Verse

Binding Molecules For Bcma And Cd3

PatentPatent Analysis

EP2780375

AMGEN
Application Number
EP12805432A
Filing Date
Nov 15, 2012
Status
Revoked
May 31, 2024
Grant Date
Sep 11, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3661562B1
EP3570885B1
EP4209499B1

Bibliography

The patent EP2780375B1 was granted to Amgen on Sep 11, 2019 following the initial filing on Nov 15, 2012 under the application number EP12805432A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SANOFIJun 12, 2020ADMISSIBLE
JAMES POOLEJun 11, 2020ADMISSIBLE
MATHYS & SQUIREJun 11, 2020ADMISSIBLE
REGENERON PHARMACEUTICALSJun 11, 2020ADMISSIBLE
TENEOBIOJun 10, 2020WITHDRAWN
PFIZERMay 4, 2020WITHDRAWN
JANSSEN BIOTECHApr 14, 2020ADMISSIBLE
ABBVIEMar 6, 2020ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents